Duopharma Biotech eyes more halal exports to Indonesia


KLANG: Duopharma Biotech Bhd has anticipated higher halal pharmaceuticals demand from Indonesia in the near term under its export expansion plan.

Its group managing director Leonard Ariff Abdul Shatar said Indonesia is moving towards implementing a law, originally slated for 2022 or 2023, that mandates halal certification for over-the-counter pharmaceutical products.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Pestec appoints Adam Yee as president
Wawasan Dengkil and Kester partner on renewable energy projects
Binastra's unit inks tripartite agreement involving RM305mil contract
Ringgit ends lower as firmer US dollar weighs on market
Infomina posts higher 2Q profit, declares 1.35 sen dividend
SkyGate acquires property investment firm for RM76mil
Berjaya Land proposes name change to Berjaya Property
SCIB shareholders approve rights issue, share capital reduction
SC Estate Builder to acquire 25% stake in non-operational hotel for RM18.79mil
FBM KLCI on a roll, notches fifth straight gain

Others Also Read